Complexes Between Cl - Inhibitor , Kallikrein , High Molecular Weight Kininogen
نویسنده
چکیده
When normal human plasma was adsorbed at 4 C with monosEecific antibody globulins to human Cl -INH inhibitor (anti-Cl -INH). Cl -INH was removed from the plasma in proportion to the amount of antibody globulins used. Clotting activity attributable to Fletcher factor (prekallikreinh high molecular weight kininogen (HMW-K). and irregularly. plasma thromboplastin antecedent (PTA. factor Xl) were also removed by these antibody globulins. and the removal of PTA and HMW-K was dependent on the presence of the prekallikrein. Plasma kallikrein and HMW-K antigen concentrations were also reduced by adsorption with antiCl -INH. Neither prekallikrein. high molecular weight kininogen. nor PTA was removed from plasma of persons with hereditary angioneurotic edema_containing any of three different types of dysmorphic Cl -INH proteins. Hageman factor was not removed from normal plasma by this
منابع مشابه
Complexes Between Cl - Inhibitor , Kallikrein , High Molecular Weight Kininogen , Plasma Thromboplastin
When normal human plasma was adsorbed at 4 C with monosEecific antibody globulins to human Cl -INH inhibitor (anti-Cl -INH). Cl -INH was removed from the plasma in proportion to the amount of antibody globulins used. Clotting activity attributable to Fletcher factor (prekallikreinh high molecular weight kininogen (HMW-K). and irregularly. plasma thromboplastin antecedent (PTA. factor Xl) were a...
متن کاملNewand Rapid Functional Assay for Cl Inhibitor in Human Plasma
c i’ inhibitor (Ci-INH) and a2-macroglobulin (a2M) account for over 90% of the inactivation of purified plasma kallikrein by normal human plasma. The rate of kallikrein inactivation is also dependent on the presence of high molecular weight kininogen (HMWK). which forms a reversible complex with kallikrein protecting the active site of the enzyme against inhibitors. By selectively mactivating a...
متن کاملInactivation of kallikrein in human plasma.
Human plasma kallikrein is inactivated by plasma protease inhibitors. This study was designed to determine the nature of these protease inhibitors and to assess their relative importance in the inactivation of kallikrein. Therefore, the kinetics of kallikrein inactivation and the formation of kallikrein inhibitor complexes were studied in normal plasma and in plasma depleted of either alpha 2-m...
متن کاملTissue kallikrein is synthesized and secreted by human vascular endothelial cells.
The generation of kinins on the surface of vascular endothelium has been postulated in two pathways involving plasma kallikrein and tissue kallikrein; the former pathway has been well documented, but the latter is controversial. To clarify the presence of a kinin-generating system on endothelium, we examined whether human umbilical vein endothelial cells (HUVEC) synthesize and release tissue ka...
متن کاملEffect of cleavage of the heavy chain of human plasma kallikrein on its functional properties.
Human plasma kallikrein consists of an N-terminal heavy chain of molecular weight (mol wt) 52,000, linked by disulfide bonds to two light chain variants (mol wt 36,000 or 33,000). Although the active catalytic site of kallikrein resides on the C-terminal light chain, the role of the N-terminal heavy chain is less clear. We therefore studied an enzyme designated beta-kallikrein, containing a sin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2005